FR2288107B1 - - Google Patents

Info

Publication number
FR2288107B1
FR2288107B1 FR7601712A FR7601712A FR2288107B1 FR 2288107 B1 FR2288107 B1 FR 2288107B1 FR 7601712 A FR7601712 A FR 7601712A FR 7601712 A FR7601712 A FR 7601712A FR 2288107 B1 FR2288107 B1 FR 2288107B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7601712A
Other versions
FR2288107A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of FR2288107A1 publication Critical patent/FR2288107A1/fr
Application granted granted Critical
Publication of FR2288107B1 publication Critical patent/FR2288107B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7601712A 1974-06-03 1976-01-22 Procede pour transformer la niddamycine en carbomycine b et en o3-esters correspondants, et nouveaux composes et carbomycine b obtenus par ce procede Granted FR2288107A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/476,016 US3970642A (en) 1974-06-03 1974-06-03 Process for the conversion of niddamycin to leucomycin A1, leucomycin A3, carbomycin B and other antibiotics and related 3-O-esters

Publications (2)

Publication Number Publication Date
FR2288107A1 FR2288107A1 (fr) 1976-05-14
FR2288107B1 true FR2288107B1 (fr) 1980-02-22

Family

ID=23890150

Family Applications (3)

Application Number Title Priority Date Filing Date
FR7517321A Granted FR2288749A1 (fr) 1974-06-03 1975-06-03 Procedes pour transformer la niddamycine en leucomycine a1, leucomycine a3, carbomycine b et autres antibiotiques et en o3-esters correspondants et nouveaux composes obtenus par ces procedes
FR7601711A Granted FR2288106A1 (fr) 1974-06-03 1976-01-22 Procede pour transformer la niddamycine en leucomycine a3 et en o3-esters correspondants, et nouveaux composes et leucomycine a3 obtenus par ce procede
FR7601712A Granted FR2288107A1 (fr) 1974-06-03 1976-01-22 Procede pour transformer la niddamycine en carbomycine b et en o3-esters correspondants, et nouveaux composes et carbomycine b obtenus par ce procede

Family Applications Before (2)

Application Number Title Priority Date Filing Date
FR7517321A Granted FR2288749A1 (fr) 1974-06-03 1975-06-03 Procedes pour transformer la niddamycine en leucomycine a1, leucomycine a3, carbomycine b et autres antibiotiques et en o3-esters correspondants et nouveaux composes obtenus par ces procedes
FR7601711A Granted FR2288106A1 (fr) 1974-06-03 1976-01-22 Procede pour transformer la niddamycine en leucomycine a3 et en o3-esters correspondants, et nouveaux composes et leucomycine a3 obtenus par ce procede

Country Status (5)

Country Link
US (1) US3970642A (fr)
JP (1) JPS514189A (fr)
CA (1) CA1048019A (fr)
FR (3) FR2288749A1 (fr)
GB (1) GB1502791A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4851518A (en) * 1985-12-23 1989-07-25 Schering Corporation Di and tri-O-acetyl-"O-iso-valeryl-23-O-demycinosyl tylosins, hydrazone derivatives thereof and processes for their preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3792035A (en) * 1970-05-04 1974-02-12 Meiji Seika Kaisha Mono-acetyl derivatives of antibiotic sf-837 and sf-837-a2 substances and production thereof
US3784447A (en) * 1972-04-17 1974-01-08 Abbott Lab Mycarosyl macrolide antibiotics
DE2361059A1 (de) * 1973-12-07 1975-07-24 Hoechst Ag Verfahren zur herstellung von (androst-17 beta-yl)-alpha-pyronen

Also Published As

Publication number Publication date
CA1048019A (fr) 1979-02-06
FR2288749B1 (fr) 1979-07-20
FR2288106A1 (fr) 1976-05-14
US3970642A (en) 1976-07-20
GB1502791A (en) 1978-03-01
FR2288749A1 (fr) 1976-05-21
FR2288107A1 (fr) 1976-05-14
JPS514189A (fr) 1976-01-14
FR2288106B1 (fr) 1979-07-27

Similar Documents

Publication Publication Date Title
IN145978B (fr)
JPS514189A (fr)
AU495028B2 (fr)
BG26192A3 (fr)
CH576268A5 (fr)
AU482284A (fr)
AU480977A (fr)
BE836964A (fr)
BG19639A1 (fr)
BG19682A1 (fr)
BG19903A1 (fr)
BG20001A1 (fr)
BG20447A1 (fr)
BG20459A1 (fr)
BG20643A1 (fr)
BG20852A1 (fr)
BG20988A1 (fr)
BG21133A1 (fr)
BG21288A1 (fr)
BG21290A1 (fr)
BG21327A2 (fr)
BG21452A1 (fr)
BG22566A1 (fr)
BG26001A3 (fr)
CH570190A5 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse